High expression of AGBL2 is a novel prognostic factor of adverse outcome in patients with ovarian carcinoma

por He, Wei-Peng, Wang, Li-Li
Publicado 2019

Maelstrom promotes tumor metastasis through regulation of FGFR4 and epithelial-mesenchymal transition in epithelial ovarian cancer

por He, Wei-Peng, Yang, Gui-Ping, Yang, Zun-Xian, Shen, Hong-Wei, You, Ze-Shan, Yang, Guo-Fen
Publicado 2022

A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer

por He, Wei-Peng, Chen, Yu-Ying, Wu, Lin-Xiang, Guo, Yun-Yun, You, Ze-Shan, Yang, Guo-Fen
Publicado 2022

CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival

por He, Wei-Peng, Zhou, Juan, Cai, Mu-Yan, Xiao, Xiang-Shen, Liao, Yi-Ji, Kung, Hsiang-Fu, Guan, Xin-Yuan, Xie, Dan, Yang, Guo-Fen
Publicado 2012

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma

por Yang, Guo-Fen, He, Wei-Peng, Cai, Mu-Yan, He, Li-Ru, Luo, Jun-Hang, Deng, Hai-Xia, Guan, Xin-Yuan, Zeng, Mu-Sheng, Zeng, Yi-Xin, Xie, Dan
Publicado 2010

CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2

por He, Wei-Peng, Guo, Yun-Yun, Yang, Gui-Ping, Lai, Hui-Ling, Sun, Ting-Ting, Zhang, Zu -Wei, Ouyang, Ling-Long, Zheng, Yu, Tian, Li-Ming, Li, Xiao-Hui, You, Ze-Shan, Xie, Dan, Yang, Guo-Fen
Publicado 2020